Elevating the Manufacturing Process to Identify & Produce Safe Cell Therapy Doses
Time: 1:00 pm
day: Day 2 Treg Cell Therapy Track PM
Details:
Outlining methods and approaches for the development of a closed and automated manufacturing process for Tr1-based cell therapies
Detailing the operational and regulatory requirements for utilizing donor cell pooling as a technique to improve therapeutic outcomes
Improving the security and robustness of the manufacturing process to consistently produce the appropriate dose
